These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15494031)

  • 1. Dimerization of alpha1-adrenoceptors.
    Milligan G; Pediani J; Fidock M; López-Giménez JF
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):847-50. PubMed ID: 15494031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties.
    Uberti MA; Hall RA; Minneman KP
    Mol Pharmacol; 2003 Dec; 64(6):1379-90. PubMed ID: 14645668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods to monitor the quaternary structure of G protein-coupled receptors.
    Milligan G; Bouvier M
    FEBS J; 2005 Jun; 272(12):2914-25. PubMed ID: 15955052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric structure of the alpha1b-adrenoceptor: comparisons with rhodopsin.
    Milligan G; Pediani JD; Canals M; Lopez-Gimenez JF
    Vision Res; 2006 Dec; 46(27):4434-41. PubMed ID: 17005232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in alpha1-adrenergic receptor research.
    Chen ZJ; Minneman KP
    Acta Pharmacol Sin; 2005 Nov; 26(11):1281-7. PubMed ID: 16225747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.
    Szidonya L; Cserzo M; Hunyady L
    J Endocrinol; 2008 Mar; 196(3):435-53. PubMed ID: 18310440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-protein-coupled receptor signalling through protein networks.
    Strosberg AD; Nahmias C
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):23-7. PubMed ID: 17212582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-coupling properties of the invertebrate visual guanine nucleotide binding protein iGqalpha.
    Go L; Mitchell J
    Cell Signal; 2007 Sep; 19(9):1919-27. PubMed ID: 17560078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity in the oligomerisation of G protein-coupled receptors.
    Milligan G; Lopez-Gimenez J; Wilson S; Carrillo JJ
    Semin Cell Dev Biol; 2004 Jun; 15(3):263-8. PubMed ID: 15125889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective pharmacophore design for alpha1-adrenoceptor subtypes.
    MacDougall IJ; Griffith R
    J Mol Graph Model; 2006 Sep; 25(1):146-57. PubMed ID: 16406718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors as microprocessors: pharmacological nuance on metabotropic glutamate receptors 1alpha.
    Kenakin T
    Sci STKE; 2006 Jul; 2006(342):pe29. PubMed ID: 16818798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
    Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
    Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
    Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward understanding GPCR dimers.
    Parnot C; Kobilka B
    Nat Struct Mol Biol; 2004 Aug; 11(8):691-2. PubMed ID: 15280880
    [No Abstract]   [Full Text] [Related]  

  • 19. Construction of covalently coupled, concatameric dimers of 7TM receptors.
    Terpager M; Scholl DJ; Kubale V; Martini L; Elling CE; Schwartz TW
    J Recept Signal Transduct Res; 2009; 29(5):235-45. PubMed ID: 19747085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activity and inverse agonism at the alpha1adrenoceptors.
    Cotecchia S
    Biochem Pharmacol; 2007 Apr; 73(8):1076-83. PubMed ID: 17125741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.